RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
Now aspirin is no good? NEJM RCT shows no CV benefit, and increased major hemorrhagic events vs placebo. I’ve always hated aspirin. What other med impacts surgery as much? https://t.co/sGENvrWIHG
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @IntraMednet: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly https://t.co/JyTtWhie9w https://t.co/dvlQki…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
Congratulations John, @profcmreid and my former @Monash_SPHPM colleagues! @NEJM
RT @pauldub67: A pivotal moment in primary prevention ? @mmamas1973 @DrPascalMeier @sbrugaletta @hect2701 @PCRonline @EuroInterventio @Cath…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Results of the ASPREE trial, led by @MonashUni researchers are out. "The use of low-dose aspirin as a primary prevention strategy in older adults... did not result in a significantly lower risk of cardiovascular disease than placebo".
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly https://t.co/JyTtWhie9w https://t.co/dvlQkiezaa
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
Effect of aspirin on #cardiovascular events & bleeding in seniors https://t.co/1ZkTSSsc8O Low-dose #aspirin for primary prevention of #CVD in older adults resulted in significantly ⬆️ risk of major #hemorrhage & did not result in a significantly ⬇️
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
Interesting study. It’s always better not to give a drug when you are healthy especially in the elderly.
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @Alourog: (NEJM) Uso de #aspirina a dosis bajas en #prevencion primaria en adultos mayores aumenta riesgo de hemorragia y no disminuye s…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
"In older persons without known cardiovascular disease, the use of low-dose aspirin resulted in a significantly higher risk of major hemorrhage and did not result in a significantly lower risk of cardiovascular disease than placebo." https://t.co/LJJavMn
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @alebura: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ZWwbavOGni
RT @ValleAlfonso: Low-dose aspirin as a primary prevention strategy in older adults ⤴️ risk of major hemorrhage and did ⛔️not result in a s…
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
In primary prevention in elderly patients, #Aspirin does not reduce Cardiovascular Events and increases Bleeding in the Healthy Elderly https://t.co/0YyK3jUYuX
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @EricWong_MD: Increased major bleeds (intracranial & GI) with ASA 100mg daily for 1º prevention in older adults age >70. #ASPREE trial s…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @Alourog: (NEJM) Uso de #aspirina a dosis bajas en #prevencion primaria en adultos mayores aumenta riesgo de hemorragia y no disminuye s…
RT @turkerkilic: #Aspirin ’in Kalp-Damar Hastalıklarının önlenmesinde kullanılmasında *yararsız* olduğuna dair iki önemli çalışma yayınland…
RT @Alourog: (NEJM) Uso de #aspirina a dosis bajas en #prevencion primaria en adultos mayores aumenta riesgo de hemorragia y no disminuye s…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
An asprin a day doesn't necessarily keep the doctor away...(if over 70 with no previous cardiovascular incidents). Interesting results: https://t.co/yIDylOyVUk Proud to be working with some of the amazing people from this trial as part of my PhD! @PaulL
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @Alourog: (NEJM) Uso de #aspirina a dosis bajas en #prevencion primaria en adultos mayores aumenta riesgo de hemorragia y no disminuye s…
RT @Derek_Leong_RPh: ASPREE (Part 2) - In patients > 70 years old without CVD, ASA for primary prevention did not reduce MACE vs. placebo,…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/VtWJYVF8qG
ASPREE (Part 2) - In patients > 70 years old without CVD, ASA for primary prevention did not reduce MACE vs. placebo, but did increase risk of major bleeding (mainly UGIB and ICH).
RT @aakonc: Bleeding rates w aspirin are consistently underestimated, I blame the "baby" nomenclature which makes it sound so innocuous htt…
Effets de l'asprine sur la survie sans handicap chez les sujets âgés en bonne santé https://t.co/BHpzsGR3Bp via @NEJM https://t.co/TIHbCHbeJ7
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ArmandGirbes: Important study outcome: lack of beneficial effect of low-dose Aspirin for primary prevention in the elderly. https://t.c…
Effets de l'aspirine sur les événements cardiovasculaires et les saignements chez les sujets âgés sains https://t.co/BHpzsGR3Bp via @NEJM https://t.co/kFJ4Nfthmq
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
Important
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @fcanestro: ¿ Que os parece si esta semana le dedicamos un ratito a revisar a los mayores de 70 años sanos que tienen en su tratamiento…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @ArmandGirbes: Important study outcome: lack of beneficial effect of low-dose Aspirin for primary prevention in the elderly. https://t.c…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @sean9n: Aspirin for primary prevention in older people? Just say no. Important to actively stop this drug https://t.co/Dpl1pr5rnG
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @alebura: Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly | NEJM https://t.co/ZWwbavOGni
Good work. As we already know that aspirin for primary prevention has little benefit, no different here (still trends toward benefit, just not stat. sig.). Again, risk/benefit in elderly is the issue. Great opportunity for deprescribing. But why aspirin fo
RT @krychtiukmd: A series of articles in @nejm randomizing "healthy elderly" (>70yrs / n>19.000 /w/o CVD) to aspirin 100mg/d vs. placebo sh…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @NEJM: Original Article: Effect of #Aspirin on CV Events and Bleeding in the Healthy Elderly (ASPREE) https://t.co/XPjVR3gDh4 https://t.…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…
RT @CMichaelGibson: In primary prevention in elderly patients, Aspirin does not reduce Cardiovascular Events and increases Bleeding in the…
RT @doctormacias: En ancianos sanos, la aspirina NO reduce los infartos y embolias, y SÍ aumenta el riesgo de hemorragias. https://t.co/oP…